12 employees
We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
2011
$1.5M
from 2 investors over 2 rounds
DestiNA Genomics Ltd. raised $1.5M on October 2, 2014
Investors: Vitro S.A. and Old College Capital